Lindbrook Capital, LLC Soleno Therapeutics Inc Transaction History

Lindbrook Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 27, 2020	SELL	$1.77 - $4.23 $16,638 - $39,762	-9,400 Closed	0 $0
Q1 2020 Apr 22, 2020	SELL	$1.64 - $3.85 $2,624 - $6,160	-1,600 Reduced 14.55%	9,400 $22,000
Q4 2019 Jan 27, 2020	BUY	$1.35 - $2.95 $14,850 - $32,450	11,000 New	11,000 $32,000
Q3 2019 Oct 31, 2019	SELL	$1.5 - $2.99 $16,500 - $32,890	-11,000 Closed	0 $0
Q2 2019 Jul 24, 2019	BUY	$1.93 - $2.95 $21,230 - $32,450	11,000 New	11,000 $30,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $413M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.